A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)

Clinical trial NCT00591526 · COMPLETED

Trial details

NCT number: NCT00591526
Sponsor: Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Promyelocytic, Acute

Start date: 2000-06-01
Primary completion: 2004-06-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.